We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
DiaSorin gained the rights to commercialize the test for use on its Liaison analyzer platform in the U.S. in a September 2020 licensing deal with MeMed. Read More
Currently, less than 0.2 percent of adults with obesity are treated surgically for obesity, leaving a substantial unmet need, the company said. Read More